![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
01 AbbVie Inc (2)
02 Aspen Pharmacare Holdings (3)
03 Alembic Pharmaceuticals Limited (2)
04 Apotex Inc (2)
05 Aurobindo Pharma Limited (2)
06 Cipla (2)
07 ENDO OPERATIONS (2)
08 Inventia Healthcare Limited (2)
09 JAMP PHARMA (2)
10 Jubilant Generics (2)
11 Macleods Pharmaceuticals Limited (6)
12 Meru Labs Luxco S.à rl, (2)
13 Merus Labs Luxco S. à R. L. (6)
14 Merz Pharma (4)
15 PolyGen Pharmaceuticals (2)
16 SEARCHLIGHT PHARMA INC (2)
17 Torrent Pharmaceuticals Limited (2)
18 Xiromed (2)
19 Blank (8)
01 Depottablett (6)
02 ER TABLET (2)
03 ER Tablet (8)
04 Extended Release Tablet (2)
05 PROLONGED-RELEASE TABLET (2)
06 SRT (2)
07 TAB (3)
08 TABLET (EXTENDED-RELEASE) (6)
09 TABLET, EXTENDED RELEASE;ORAL (20)
10 Tablet (4)
01 Countries Registered In: US (Filed 2013) (2)
02 DISCN (8)
03 Generic (2)
04 Generic US CTD (2)
05 Originator (3)
06 Prescription (6)
07 RX (12)
08 Registered in US (6)
09 US (Filed 2013) (2)
10 Blank (12)
01 APO-DARIFENACIN (2)
02 DARIFENACIN (2)
03 DARIFENACIN HYDROBROMIDE (16)
04 ENABLEX (4)
05 Emselex (8)
06 Enablex 15mg (1)
07 Enablex 7,5mg (2)
08 Floden CR 15 mg (1)
09 Floden CR 7.5 mg (1)
10 JAMP DARIFENACIN (2)
11 Blank (16)
01 Canada (6)
02 India (8)
03 Norway (6)
04 South Africa (5)
05 Sweden (2)
06 Switzerland (4)
07 USA (20)
08 United Kingdom (2)
09 Blank (2)